Senseonics Holdings, Inc. (SENS)
Senseonics Holdings, Inc. (SENS) is a medical technology company that develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes. Known for its implantable Eversense CGM system, the company aims to improve diabetes management through innovative, long-term sensor solutions that provide real-time glucose data.
Company News
Senseonics reported Q3 preliminary revenue of $8.1 million, a 91% year-over-year increase, but announced a 1-for-20 reverse stock split that reduced outstanding shares from 816 million to 41 million, causing stock price to drop.
Senseonics Holdings, Inc. announced the closing of a public offering of 115 million shares of its common stock, raising $57.5 million in gross proceeds. The company also closed a private placement with Abbott Laboratories, who acquired 40.5 million shares for $20.3 million. The proceeds will be used to fund the launch of Eversense 365 and develop...
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
Best penny stocks to buy right now? Here are 4 to watch in the stock market today. The post Top Penny Stocks To Buy Now? 4 To Watch Under $4 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.